MXPA03005944A - Anticuerpos humanos especificos para terapia selectiva de cancer. - Google Patents
Anticuerpos humanos especificos para terapia selectiva de cancer.Info
- Publication number
- MXPA03005944A MXPA03005944A MXPA03005944A MXPA03005944A MXPA03005944A MX PA03005944 A MXPA03005944 A MX PA03005944A MX PA03005944 A MXPA03005944 A MX PA03005944A MX PA03005944 A MXPA03005944 A MX PA03005944A MX PA03005944 A MXPA03005944 A MX PA03005944A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide
- polypeptide
- cell
- seq
- region
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75118100A | 2000-12-29 | 2000-12-29 | |
| PCT/US2001/049440 WO2002059264A2 (en) | 2000-12-29 | 2001-12-31 | Specific human antibodies for selective cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03005944A true MXPA03005944A (es) | 2005-04-29 |
Family
ID=25020844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03005944A MXPA03005944A (es) | 2000-12-29 | 2001-12-31 | Anticuerpos humanos especificos para terapia selectiva de cancer. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1353937A4 (zh) |
| JP (1) | JP2004524023A (zh) |
| KR (1) | KR20030091952A (zh) |
| CN (1) | CN100374456C (zh) |
| AU (1) | AU2002246737B2 (zh) |
| BR (1) | BR0116763A (zh) |
| CA (1) | CA2433227A1 (zh) |
| CZ (1) | CZ20031983A3 (zh) |
| HU (1) | HUP0400775A2 (zh) |
| IL (1) | IL156690A0 (zh) |
| MX (1) | MXPA03005944A (zh) |
| NZ (1) | NZ527173A (zh) |
| PL (1) | PL365758A1 (zh) |
| RU (1) | RU2316564C2 (zh) |
| WO (1) | WO2002059264A2 (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2491427A1 (en) * | 2002-07-01 | 2004-01-08 | Savient Pharmaceuticals, Inc. | Compositions and methods for therapeutic treatment |
| CA2531283A1 (en) * | 2003-06-30 | 2005-01-20 | Bio-Technology General (Israel) Ltd. | Specific human antibodies |
| MX2007013304A (es) | 2005-04-26 | 2007-12-13 | Pfizer | Anticuerpos de p-caderina. |
| WO2010078916A1 (en) * | 2008-12-19 | 2010-07-15 | Philogen S.P.A. | Immunocytokines for tumour therapy with chemotherapeutic agents |
| US9211344B2 (en) * | 2010-07-09 | 2015-12-15 | Affibody Ab | Polypeptides |
| CN101948534B (zh) * | 2010-08-19 | 2014-05-28 | 中国科学院生物物理研究所 | 一种筛选抗体的方法 |
| GB201310544D0 (en) * | 2013-06-13 | 2013-07-31 | Ucb Pharma Sa | Obtaining an improved therapeutic ligand |
| ES2731876T3 (es) * | 2014-10-23 | 2019-11-19 | Singh Molecular Medicine Llc | Anticuerpos de dominio sencillo contra antígenos intracelulares |
| CA2970255A1 (en) * | 2014-12-17 | 2016-06-23 | Intrexon Corporation | Intercalated single-chain variable fragments |
| GB201506868D0 (en) * | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method for protein purification |
| CN114195882A (zh) * | 2015-10-01 | 2022-03-18 | 圣拉斐尔医院有限公司 | Tcr及其用途 |
| AU2016358296B2 (en) * | 2015-11-19 | 2020-05-21 | Revitope Limited | Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells |
| DK4050034T3 (da) * | 2016-09-14 | 2024-06-03 | Teneoone Inc | Cd3-bindende antistoffer |
| WO2022103961A1 (en) * | 2020-11-13 | 2022-05-19 | Prometheus Biosciences, Inc. | Methods, systems, and kits for treatment of inflammatory diseases targeting tl1a |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997002479A2 (en) * | 1995-06-30 | 1997-01-23 | Yale University | Human monoclonal anti-tumor antibodies |
| BR9806793A (pt) * | 1997-01-22 | 2000-05-16 | Univ Texas | Processos e composições de fator tissular para coagulação e tratamento de tumores. |
-
2001
- 2001-12-31 CZ CZ20031983A patent/CZ20031983A3/cs unknown
- 2001-12-31 AU AU2002246737A patent/AU2002246737B2/en not_active Ceased
- 2001-12-31 CN CNB018228852A patent/CN100374456C/zh not_active Expired - Fee Related
- 2001-12-31 JP JP2002559551A patent/JP2004524023A/ja active Pending
- 2001-12-31 HU HU0400775A patent/HUP0400775A2/hu unknown
- 2001-12-31 CA CA002433227A patent/CA2433227A1/en not_active Abandoned
- 2001-12-31 PL PL01365758A patent/PL365758A1/xx unknown
- 2001-12-31 MX MXPA03005944A patent/MXPA03005944A/es not_active Application Discontinuation
- 2001-12-31 BR BR0116763-4A patent/BR0116763A/pt not_active IP Right Cessation
- 2001-12-31 IL IL15669001A patent/IL156690A0/xx unknown
- 2001-12-31 EP EP01994329A patent/EP1353937A4/en not_active Withdrawn
- 2001-12-31 RU RU2003123100/13A patent/RU2316564C2/ru not_active IP Right Cessation
- 2001-12-31 WO PCT/US2001/049440 patent/WO2002059264A2/en active IP Right Grant
- 2001-12-31 NZ NZ527173A patent/NZ527173A/xx unknown
- 2001-12-31 KR KR10-2003-7008885A patent/KR20030091952A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20031983A3 (cs) | 2005-07-13 |
| NZ527173A (en) | 2006-03-31 |
| HUP0400775A2 (en) | 2007-05-02 |
| KR20030091952A (ko) | 2003-12-03 |
| JP2004524023A (ja) | 2004-08-12 |
| AU2002246737B2 (en) | 2007-03-01 |
| CN100374456C (zh) | 2008-03-12 |
| WO2002059264A2 (en) | 2002-08-01 |
| WO2002059264A3 (en) | 2003-03-06 |
| IL156690A0 (en) | 2004-01-04 |
| EP1353937A2 (en) | 2003-10-22 |
| CN1551886A (zh) | 2004-12-01 |
| EP1353937A4 (en) | 2005-04-13 |
| BR0116763A (pt) | 2004-03-09 |
| PL365758A1 (en) | 2005-01-10 |
| RU2003123100A (ru) | 2005-03-10 |
| RU2316564C2 (ru) | 2008-02-10 |
| CA2433227A1 (en) | 2002-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070149768A1 (en) | Specific human antibodies for selective cancer therapy | |
| AU2001249760B2 (en) | Mucin-1 specific binding members and methods of use thereof | |
| KR101570702B1 (ko) | 단일클론 인간 종양-특이적 항체 | |
| US20040002450A1 (en) | Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof | |
| EP0483961A1 (en) | Specific binding agents | |
| AU2001249760A1 (en) | Mucin-1 specific binding members and methods of use thereof | |
| US20040001822A1 (en) | Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof | |
| AU2002246737B2 (en) | Specific human antibodies for selective cancer therapy | |
| US20040001839A1 (en) | Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof | |
| AU2002246737A1 (en) | Specific human antibodies for selective cancer therapy | |
| MXPA03005945A (es) | Moleculas aisladas que comprenden epitopes que contienen grupos sulfato, anticuerpos para tales epitopes y usos de ellos. | |
| JP2005503756A5 (zh) | ||
| US20040202665A1 (en) | Compositions and methods for therapeutic treatment | |
| AU2003263764A1 (en) | Antibodies and uses thereof | |
| MXPA06000252A (es) | Anticuerpos y usos de los mismos. | |
| KR20050059001A (ko) | 치료적 처리를 위한 조성물 및 방법 | |
| JPWO2009066655A1 (ja) | アポトーシス誘導能を有するヒト抗体 | |
| US20040208877A1 (en) | Antibodies and uses thereof | |
| AU2002246738A1 (en) | Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |